Abstract:GG and XX are co-corresponding authors Corneal diseases are the second major cause of blindness worldwide. Corneal neovascularization (CNV) is one of the most common pathological processes in corneal diseases, leading to vision loss or even blindness in patients. However, even though different treatments for CNV are available in clinic, a safe and effective therapy remains to be an unmet medical challenge. MicroRNAs (miRNAs) play roles in regulating more than half of all protein-coding genes in mammals including those involved with angiogenesis. Therefore, modulating expression of angiogenesis-related miRNAs might be an effective approach for treating this blindness-causing corneal lesion. To this end, we first tested four angiogenesis-related miRNAs (i. e. miR-126, miR-10, miR-17a and miR-92) for their role in angiogenesis in vitro by assessing cell proliferation and tube formation of VEGF-stimulated human umbilical vein endothelial cells (HUVECs) transfected with the plasmid constructs overexpressing the pri-miRNAs or Tough Decoy (Tud) RNAs inhibitory to the corresponding target miRNAs. We found that TuD-miR-10b, pri-miR-17a and pri-miR-92 were significantly inhibitory for the cell proliferation and tube formation of HUVECs, while TuD-miR-126-5p could impede HUVEC tube formation but not proliferation. Our data reveal that miR-126 and miR-10 are pro-angiogenic regulators, whereas miR-17a and miR-92 are negative regulators of angiogenesis, suggesting the feasibility of using miRNA as therapeutic targets to modulate angiogenesis in CNV. We next set out to identify more target miRNAs that play roles in CNV. To date, there has been no report on miRNA expression profile of CNV. Using Nanostring technologies and the classic alkali-burn induced CNV mouse model, we profiled small RNAs prepared from the corneal tissues harvested from the study mice before and days 5, 10 and 15 after alkali injury for expression levels of 618 mouse miRNAs. We found 35 up-regulated and 3 down-regulated miRNAs in the mouse neovascularized corneas. Currently, we are in the process of confirming expression profiles of those candidate target miRNAs by qRT-PCR. For proof-of-concept, we proposed to use rAAV vector for efficient delivery of those pri-miRNAs or their corresponding Tud RNAs to the corneas of alkali-burn induced CNV mice and evaluate their potency in preventing or treating CNV. To this end, we first assessed several serotypes of rAAV EGFP for gene transfer efficiency in mouse corneas after delivery by ectopic eye drops, or intrastromal or subconjunctival injections to identify the most efficient AAV serotype and method of delivery for miRNA therapeutics. The results of those experiments will be presented. In sum, our study has great clinical relevance; miRNA-targeted novel therapeutics that can be delivered as either rAAV or synthetic nucleic acid drugs (i. e. miRNA mimics and antagomir) might offer an additional clinical option for treating CNV.

Impaired Autophagy Causes Severe Corneal Neovascularization

Neutrophil extracellular traps promote corneal neovascularization-induced by alkali burn

Histone Methylation Regulates Neutrophil Extracellular Traps to Attenuate Corneal Neovascularization

Critical Role of TNF-α-Induced Macrophage VEGF and Inos Production in the Experimental Corneal Neovascularization

Enhanced autophagy alleviated corneal allograft rejection via inhibiting NLRP3 inflammasome activity

Intravenous Route to Choroidal Neovascularization by Macrophage-Disguised Nanocarriers for Mtor Modulation

Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse <i>TSC1</i> and <i>mTOR</i> genes

Activated Macrophages Induce Neovascularization Through Upregulation of MMP-9 and VEGF in Rat Corneas.

Enhanced Experimental Corneal Neovascularization Along With Aberrant Angiogenic Factor Expression In The Absence Of Il-1 Receptor Antagonist

Inhibiting PRMT1 protects against CoNV by regulating macrophages through the FGF2/PI3K/Akt pathway

The potential protective effects of miR-497 on corneal neovascularization are mediated via macrophage through the IL-6/STAT3/VEGF signaling pathway

Critical role of SDF-1 alpha-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization

586. Development of Anti-Angiogenic Mirna Therapeutics for Corneal Neovascularization

Effect of exogenous TNF-α on corneal neovascularization induced by alkali burn

Inhibitory Effect Of Ccr3 Signal On Alkali-Induced Corneal Neovascularization

Upadacitinib Inhibits Corneal Inflammation and Neovascularization by Suppressing M1 Macrophage Infiltration in the Corneal Alkali Burn Model.

Anti-apoptosis Effects of Vascular Endothelial Cadherin in Experimental Corneal Neovascularization.

Rapamycin Antagonizes Angiogenesis and Lymphangiogenesis Through Myeloid-Derived Suppressor Cells in Corneal Transplantation

Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization

Targeting HMGB1-NFκb Axis and miR-21 by Glycyrrhizin: Role in Amelioration of Corneal Injury in a Mouse Model of Alkali Burn

Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages